skeleton
N |
• normal osteoclastogenesis in the presence of FCGR4 cross-linking antibodies
|
• no reduction in clinical signs of arthritis in the presence of FCGR4 cross-linking antibodies
|
• reduced bone erosion in the presence of FCGR4 cross-linking antibodies
|
homeostasis/metabolism
• reduced serum collagen 1 fragments in the presence of FCGR4 cross-linking antibodies
|
immune system
• no reduction in clinical signs of arthritis in the presence of FCGR4 cross-linking antibodies
|
hematopoietic system